Exhibit 107
Calculation of Filing Fee Tables
F-1
(Form Type)
Evaxion Biotech A/S
(Exact Name of Registrant as Specified in its Charter)
N/A
(Translation of Registrant’s Name into English)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit(2) | Maximum Aggregate Offering Price(2) | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to Be Paid | Equity | Ordinary Shares DKK 1 nominal value (1) | 457(c) 457(h) | 4,649,250 | $1.96 | $9,112,530 | 0.0000927 | $845.00 | ||||||||||||||||
Fees Previously Paid | _ | _ | _ | _ | _ | _ | _ | |||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Total Offering Amounts | $ | 9,112,530 | ||||||||||||||||||||||
Total Fees Previously Paid | N/A | |||||||||||||||||||||||
Total Fee Offsets | N/A | |||||||||||||||||||||||
Net Fee Due | $ | 845.00 |
(1) | The ordinary shares registered hereby will be represented by American Depositary Shares (“ADSs”), each of which will represent one ordinary share of the registrant. Such ADSs issuable on deposit of the ordinary shares registered hereby have been registered under a separate registration statement on Form F-6 (File No.: 333-252038). |
(2) | Estimated pursuant to Rules 457(c) and 457(h) under the Securities Act, solely for the purposes of calculating the registration fee and based on the average of the high and low prices of the Registrant’s common stock as reported on The Nasdaq Capital Market on June 30, 2022, which date is within five business days prior to the filing of this Registration Statement. |